Health
Enveda Raises $311 Million to Advance Nature-Derived AI Drugs Into Clinical Trials
AI biotech Enveda has secured $311 million in Series E funding at a $2 billion valuation to expand its pipeline of nature-derived…
AI biotech Enveda has secured $311 million in Series E funding at a $2 billion valuation to expand its pipeline of nature-derived…